EUVIMEDEUVIMED entdecken
ValidierungsstudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Development and validation of a risk stratification score for hemophagocytic syndrome in chronic active Epstein-Barr virus infection: A 10-year retrospective cohort study

Fei Hu, Jiayi Zhan, Meijuan Peng, Haifeng Hu, Xuyang Zheng, Danfeng Ren, Rui Li, Hong Du, Wen Tian, Zhanhu Bi, Denghui Yu, Hongkai Xu und 6 weitere

Journal of Infection and Public Health · 2026

DOI: 10.1016/j.jiph.2025.103061 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Infection and Public Health, 2026. Verfasst von Fei Hu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases Tangdu Hospital of Fourth Military Medical University, Xi'an, Shaanxi Province 710038, China; Department of Infecti…. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aims to identify risk factors for the development of hemophagocytic lymphohistiocytosis (HLH) within three years among patients with chronic active Epstein-Barr virus infection (CAEBV) and to construct a risk stratification score. METHODS: A retrospective cohort study was conducted involving 165 patients with CAEBV admitted to two infectious disease centers in Northwest China between January 2012 and December 2022, through which we identified independent risk factors for HLH. Cox regression was utilized to establish the nomogram model and generate the risk stratification score. The discrimination and clinical utility of both the nomogram and score models were subsequently assessed using calibration plots, receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and cross-validation. RESULTS: Among the 165 patients, 98 (59.4 %) developed HLH within three years. The median progression time was 405 days (IQR: 217, 740), with cumulative incidence rates of HLH at 1, 2, and 3 years of 41.3 %, 56.1 %, and 65.9 %, respectively. Five independent predictors were identified: cytopenia (HR: 1.70, 95 % CI: 1.07-2.70), EBV-DNA load in plasma (HR: 2.02, 95 % CI: 1.46-2.80), alanine aminotransferase (HR: 1.34, 95 % CI: 1.12-1.60), ferritin (HR: 1.01, 95 % CI: 1.01-1.01), and triglycerides (HR: 1.21, 95 % CI: 1.05-1.38). Both the nomogram and simplified score model demonstrated excellent discrimination (AUC > 0.7) and reliable calibration within a 3-year timeframe. The score model exhibited predictive power comparable to the nomogram, as indicated by net reclassification index and integrated discrimination index analyses. CONCLUSION: The validated nomogram and score model facilitate rapid HLH risk stratification in CAEBV patients, supporting clinical risk assessment and early intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticEpstein-Barr Virus InfectionsHumansRetrospective StudiesFemaleMaleChinaRisk AssessmentRisk FactorsAdultNomogramsMiddle AgedHerpesvirus 4, HumanAdolescentROC CurveYoung AdultChronic DiseaseViral LoadIncidence

Stichwörter der Autor:innen

Chronic active Epstein-Barr virus infectionEpstein-Barr virusHemophagocytic lymphohistiocytosisNomogramRisk factorsRisk stratification score

Autor:innen und Institutionen

  • Department of Infectious Diseases Tangdu Hospital of Fourth Military Medical University, Xi'an, Shaanxi Province 710038, China; Department of Infectious Diseases, 985th Hospital of Chinese People's Liberation Army, Taiy…
  • Department of Infectious Diseases Tangdu Hospital of Fourth Military Medical University, Xi'an, Shaanxi Province 710038, China.
  • Department of Infectious disease, First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an, Shaanxi Province 710075, China.
  • Pediatric Department, Taiyuan Children's Hospital, Taiyuan, Shanxi Province 030025, China.
  • Department of Intensive Care Unit, PLA General Hospital of Southern Theater Command, Guangzhou, Guangdong Province 510010, China.
  • Department of Infectious Diseases, PLA 960th Hospital, Jinan, Shandong Province 250033, China.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Hu, F., Zhan, J., Peng, M., Hu, H., Zheng, X., Ren, D., Li, R., Du, H., Tian, W., Bi, Z., Yu, D., Xu, H., Yang, X., Liang, Y., Li, F., Hou, J., He, Y., & Lian, J. (2026). Development and validation of a risk stratification score for hemophagocytic syndrome in chronic active Epstein-Barr virus infection: A 10-year retrospective cohort study. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.103061

Vancouver

Hu F, Zhan J, Peng M, Hu H, Zheng X, Ren D, et al. Development and validation of a risk stratification score for hemophagocytic syndrome in chronic active Epstein-Barr virus infection: A 10-year retrospective cohort study. Journal of Infection and Public Health. 2026. doi:10.1016/j.jiph.2025.103061

BibTeX
@article{Hu2026,
  author = {Hu, Fei and Zhan, Jiayi and Peng, Meijuan and Hu, Haifeng and Zheng, Xuyang and Ren, Danfeng and Li, Rui and Du, Hong and Tian, Wen and Bi, Zhanhu and Yu, Denghui and Xu, Hongkai and Yang, Xiaofei and Liang, Yan and Li, Fangfang and Hou, Jingtao and He, Yingli and Lian, Jianqi},
  title = {Development and validation of a risk stratification score for hemophagocytic syndrome in chronic active Epstein-Barr virus infection: A 10-year retrospective cohort study},
  journal = {Journal of Infection and Public Health},
  year = {2026},
  doi = {10.1016/j.jiph.2025.103061}
}
Kostenlos starten →